These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 28594323)

  • 41. Deciphering the crucial residues involved in heterodimerization of Bak peptide and anti-apoptotic proteins for apoptosis.
    Marimuthu P; Singaravelu K
    J Biomol Struct Dyn; 2018 May; 36(6):1637-1648. PubMed ID: 28511583
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The C-terminal Domains of Apoptotic BH3-only Proteins Mediate Their Insertion into Distinct Biological Membranes.
    Andreu-Fernández V; García-Murria MJ; Bañó-Polo M; Martin J; Monticelli L; Orzáez M; Mingarro I
    J Biol Chem; 2016 Nov; 291(48):25207-25216. PubMed ID: 27758854
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High-throughput fluorescence polarization assay for chemical library screening against anti-apoptotic Bcl-2 family member Bfl-1.
    Zhai D; Godoi P; Sergienko E; Dahl R; Chan X; Brown B; Rascon J; Hurder A; Su Y; Chung TD; Jin C; Diaz P; Reed JC
    J Biomol Screen; 2012 Mar; 17(3):350-60. PubMed ID: 22156224
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Experimental Characterization of the Binding Affinities between Proapoptotic BH3 Peptides and Antiapoptotic Bcl-2 Proteins.
    Kong W; Zhou M; Li Q; Fan W; Lin H; Wang R
    ChemMedChem; 2018 Sep; 13(17):1763-1770. PubMed ID: 30084216
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members.
    Certo M; Del Gaizo Moore V; Nishino M; Wei G; Korsmeyer S; Armstrong SA; Letai A
    Cancer Cell; 2006 May; 9(5):351-65. PubMed ID: 16697956
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A novel BH3 ligand that selectively targets Mcl-1 reveals that apoptosis can proceed without Mcl-1 degradation.
    Lee EF; Czabotar PE; van Delft MF; Michalak EM; Boyle MJ; Willis SN; Puthalakath H; Bouillet P; Colman PM; Huang DC; Fairlie WD
    J Cell Biol; 2008 Jan; 180(2):341-55. PubMed ID: 18209102
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of the BH3-only protein Puma as a direct Bak activator.
    Dai H; Pang YP; Ramirez-Alvarado M; Kaufmann SH
    J Biol Chem; 2014 Jan; 289(1):89-99. PubMed ID: 24265320
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Peptide screening to knockdown Bcl-2's anti-apoptotic activity: implications in cancer treatment.
    Raghav PK; Verma YK; Gangenahalli GU
    Int J Biol Macromol; 2012 Apr; 50(3):796-814. PubMed ID: 22155216
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterization of peptide aptamers targeting Bfl-1 anti-apoptotic protein.
    Brien G; Debaud AL; Bickle M; Trescol-Biemont MC; Moncorge O; Colas P; Bonnefoy-Berard N
    Biochemistry; 2011 Jun; 50(23):5120-9. PubMed ID: 21563784
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Precision Targeting of BFL-1/A1 and an ATM Co-dependency in Human Cancer.
    Guerra RM; Bird GH; Harvey EP; Dharia NV; Korshavn KJ; Prew MS; Stegmaier K; Walensky LD
    Cell Rep; 2018 Sep; 24(13):3393-3403.e5. PubMed ID: 30257201
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tight Sequestration of BH3 Proteins by BCL-xL at Subcellular Membranes Contributes to Apoptotic Resistance.
    Pécot J; Maillet L; Le Pen J; Vuillier C; Trécesson SC; Fétiveau A; Sarosiek KA; Bock FJ; Braun F; Letai A; Tait SWG; Gautier F; Juin PP
    Cell Rep; 2016 Dec; 17(12):3347-3358. PubMed ID: 28009301
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Structural Investigation of Orf Virus Bcl-2 Homolog ORFV125 Interactions with BH3-Motifs from BH3-Only Proteins Puma and Hrk.
    Suraweera CD; Hinds MG; Kvansakul M
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372579
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Peptides derived from BH3 domains of Bcl-2 family members: a comparative analysis of inhibition of Bcl-2, Bcl-x(L) and Bax oligomerization, induction of cytochrome c release, and activation of cell death.
    Shangary S; Johnson DE
    Biochemistry; 2002 Jul; 41(30):9485-95. PubMed ID: 12135371
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A comparison of two strategies for affinity maturation of a BH3 peptide toward pro-survival Bcl-2 proteins.
    Zhang S; Long A; Link AJ
    ACS Synth Biol; 2012 Mar; 1(3):89-98. PubMed ID: 23651073
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Crystal structure of the Bcl-XL-Beclin 1 peptide complex: Beclin 1 is a novel BH3-only protein.
    Oberstein A; Jeffrey PD; Shi Y
    J Biol Chem; 2007 Apr; 282(17):13123-32. PubMed ID: 17337444
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anti-apoptotic Bcl-XL protein in complex with BH3 peptides of pro-apoptotic Bak, Bad, and Bim proteins: comparative molecular dynamics simulations.
    Lama D; Sankararamakrishnan R
    Proteins; 2008 Nov; 73(2):492-514. PubMed ID: 18452209
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular dynamics study of segment peptides of Bax, Bim, and Mcl-1 BH3 domain of the apoptosis-regulating proteins bound to the anti-apoptotic Mcl-1 protein.
    Zhao RN; Fan S; Han JG; Liu G
    J Biomol Struct Dyn; 2015; 33(5):1067-81. PubMed ID: 24865469
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak.
    Willis SN; Fletcher JI; Kaufmann T; van Delft MF; Chen L; Czabotar PE; Ierino H; Lee EF; Fairlie WD; Bouillet P; Strasser A; Kluck RM; Adams JM; Huang DC
    Science; 2007 Feb; 315(5813):856-9. PubMed ID: 17289999
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Functional dissection of Bfl-1, a Bcl-2 homolog: anti-apoptosis, oncogene-cooperation and cell proliferation activities.
    D'Sa-Eipper C; Chinnadurai G
    Oncogene; 1998 Jun; 16(24):3105-14. PubMed ID: 9671389
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Targeting Bfl-1 via acute CDK9 inhibition overcomes intrinsic BH3-mimetic resistance in lymphomas.
    Boiko S; Proia T; San Martin M; Gregory GP; Wu MM; Aryal N; Hattersley M; Shao W; Saeh JC; Fawell SE; Johnstone RW; Drew L; Cidado J
    Blood; 2021 May; 137(21):2947-2957. PubMed ID: 33259592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.